Background: The association between epilepsy and depressive illness has long been established. However, though various explanations-psychosocial and anatomical-have been proposed findings from studies are inconsistent and often contradictory.
INTRODUCTION
An association between epilepsy and depressive illness has long been recognised (at least since Hippocrates 1 ) though establishing the mechanism behind this has proved more elusive. Dysphoric symptoms are common peri-ictally and are usually considered to share an aetiology with the epileptic attacks. The cause of an increased incidence of inter-ictal depressive illness is, however, thought to be multifactorial and more varied. Links with laterality of focus have not been consistent between studies though there does seem to be a more specific association with temporal lobe epilepsy 2 and a greater weight of evidence to suggest a left sided association [3] [4] [5] . Psychosocial factors are frequently put forward to explain this increased prevalence with Hermann 6 describing it as analogous to the learned helplessness theory of depression by Seligmann 7 , though the evident excess in prevalence when compared with other equally disabling conditions 3 would suggest this is not a ଝ Study undertaken at The Department of Neuroscience, York District Hospital. complete explanation. To add to the already complex association between epilepsy and mood, it has been well documented that certain anti-epileptic drugs (e.g. carbamazepine, vigabatrin and topiramate) have direct effects on the patient's mood as well as some potentially distressing side-effects. It seems most likely that, as with the population as a whole, there are several factors that determine the likelihood of an individual developing a depressive illness.
One complicating factor in many of the studies to date is that the subjects have been drawn from tertiary referral centres and thus, can not be said to be representative of people with epilepsy as a whole. The population in this study were seen as a secondary service (under the care of P.C.) and, as well as a full clinical examination, were investigated with electroencephalogram (EEG) and either computerised tomography (CT scan) or nuclear magnetic resonance imaging (MRI) to establish any epileptic focus. Along with a questionnaire about the effect of epilepsy on various aspects of the patient's life, this was intended to establish the effect of anatomical and psychosocial factors on the genesis of depressive illness in those with epilepsy.
METHOD

Sample selection
All people attending at a specialist outpatient clinic during a 6 months period were initially identified. Patients were excluded from the study for the following reasons: age under 16 or over 65 years, not agreeing to take part in the study, no definite diagnosis of epilepsy made, incomplete questionnaires returned, referred from another secondary service or diagnosis of learning disability previously made.
Information collected
Information was gathered from questionnaires completed by the patient sample, from study of the case notes and, in some cases by examination by a psychiatrist. The patient questionnaires comprised the following: a series of Likert scales to identify the patient's subjective impression of the effect of epilepsy on their life (covering work, relationships, side-effects of medication, mobility and socialising), secondly a questionnaire to establish the patient's perception of frequency of attacks and past diagnosis or treatment of depressive illness, and, finally, a hospital anxiety and depression scale (HAD) 8 for completion. If the HAD suggested that the patient may have a depressive illness, then they were offered an appointment with a psychiatrist (G.B.) in order to establish whether this was truly the case and if necessary offer appropriate treatment.
The information gathered from the case notes included whether the patient had been diagnosed with, or treated for, a depressive illness in the past, the type of epilepsy diagnosed, when this diagnosis was first made, current anti-epileptic medication, reported fit frequency and the results of investigations to localise a lesion.
Definition of depressive illness
Patients were identified by whether they were, or had whilst having epilepsy, experienced a depressive illness. A depressive illness was taken to have been present in the past if there was evidence in the case notes that it had been diagnosed by a psychiatrist or general practitioner. A current episode was taken as been present if, in accordance with ICD 10, a diagnosis of moderate or severe depressive illness was made by the psychiatrist (G.B.) (usually following comple-tion of the HAD). The cut-off point for further assessment after the HAD scale was taken as a score of 8. Patients scoring 8 or more but declining interview by the psychiatrist were excluded from the study as it has been shown that whilst it is a sensitive instrument, the HAD scale has poor positive predictive value 9 .
RESULTS
One hundred and thirty patients attending the epilepsy clinic fulfilled the criteria for inclusion in the study. Of these, 78 (60%) agreed to take part in the study and fully completed the three questionnaires. Thirteen agreed to take part but failed to fully complete the questionnaires and thus, were excluded from the study. Of these 15 (19%) of the full responders had a history of depressive illness as described before and 16 (21%) had a current episode identified by HAD scale and clinical interview. A further four patients who scored over 8 on the HAD scale had to be excluded from the study as they declined an interview with the psychiatrist which would have confirmed a diagnosis of depressive illness. Between the two identified groups (never experienced depressive illness and current or history of depressive illness) there was no statistically significant difference with regard to sex, age, employment, type of epilepsy or number of anti-epileptic drugs being prescribed.
Within the questionnaire, patients were asked to indicate to what extent having epilepsy affected their lives in certain areas. This was done by use of a Likert scale and the areas of life assessed were: fatigue, work opportunity, mobility, social relationships, sexual relationships and general activity level. This should have allowed a simple overall assessment of the degree to which the patient felt handicapped by epilepsy. Of these areas, the only ones to show a significant association with depressive illness using the chi-squared test were an effect on mobility and an effect on general activity (both P < 0.001) (see Table 1 ). When this comparison was restricted to those currently diagnosed with a depressive illness, the difference was even more marked and a perceived marked effect on the individual's sexual and social relationships were also found to be associated with depressive illness.
Of the 78 patients involved in the study all had either an EEG, CT scan or MRI with most having two of these tests. This allowed comparisons to be made between those patients having an identified focus and those not. In all 34 (44%) had a focus identified and this itself was linked with depressive illness (P < 0.001) as was the focus being present on the right side (P < 0.001) (see Table 1 )-thus, those with a left sided lesion were less likely to have a depressive episode than the group as a whole. Probably the most robust finding of previous studies was an association between an anatomical feature of epilepsy and depressive illness is the presence of a temporal lobe focus 2, 3 . However, not only did this study fail to demonstrate such an association but also failed to show a trend towards this finding.
Patients who had experienced a depressive episode were more likely to have been diagnosed with epilepsy in adulthood (>21 years) than those with no such history (55 vs. 38% significant for P < 0.001) and more likely to be having one fit or more per month (16 vs. 35% significant for P < 0.001) (see Table 1 ). There was also, not surprisingly, a trend for people with depressive illness to be having more frequent attacks.
As there was a possibility of selective bias in the sample from those declining to take part in the study, the above-mentioned features were compared between the group being studied and the group declining. Using the chi-squared test no statistically significant difference was found.
Discussion
The factors identified that could be seen to indicate a psychosocial cause were diagnosis in adulthood, having more than one or more attacks per month and perceived marked reduction in mobility and general activity due to having epilepsy. However, though it is tempting to identify a causal effect which has some prima facie validity, it must be remembered that common symptoms of depressive illness itself are social withdrawal and loss of interest in outside activities. Thus, it may be that patients are simply describing their symptoms of depression and wrongly attributing them to epilepsy. It is, however, difficult to argue that epilepsy does not have a large effect on lifestyle in these areas. Driving is generally not permitted unless epilepsy is well controlled and the uncertainty of when the next attack may occur leads many people with poorly controlled epilepsy to be reluctant to leave familiar or safe environments. This loss of opportunity and difficulty adjusting to it may be one reason why those who also have a depressive illness were found to have been more likely to have been diagnosed in adulthood.
With regard to factors that would support an association linked with brain structure or activity, the findings in this study are at odds with the weight of research thus far. It is generally considered that a left sided locus rather than one on the right side, would be associated with depressive illness. The reasons for this difference are unclear. However, a few factors need to be taken into account. Firstly, it has been established that patients attending secondary care epilepsy centres have a lower incidence of depressive illness than those attending more specialist centres 10 and so, with relatively smaller numbers statistical anomalies are more likely to occur. In a similar vein, there is also the suggestion that, compared with psychosocial factors, the effect of an epileptic focus may be small 5 , again, with the result of greater likelihood of statistical artefacts. Finally, it would clearly be unwise to forget the 40% of clinic attendees who did not take part in the study. Though there was no significant difference in presence or laterality of focus when compared with the responders, little can be said about the presence or otherwise of a depressive illness. Thus, when looking for a potentially small effect, this could be crucial.
Given that depressive illness is a relatively common disorder (prevalence of 5-8% in the general population), when looking for factors that lead to develop in those with epilepsy, it is important to remember that a significant proportion could have been expected to develop the illness regardless of features of epilepsy. Similarly, this study like many others has looked at epilepsy as a whole. Given that depressive illness has a complex aetiology it is likely that different factors are relevant in different cases. For example, the learned helplessness model 7 may be more relevant in people with more than one type of seizure (as this may result in less predictability of an attack) and, thus be a factor in explaining the apparent increased incidence of depression in this specific group 11 . By studying the heterogeneous group of people with epilepsy as a whole, it is possible that factors important for some people in the aetiology of depressive illness are losing significance when a larger, more diverse group is studied.
LIMITATIONS
The multifactorial nature of depressive illness and the varying relevance of such aetiological factors between individuals has already been discussed. In order to identify these with statistical significance requires large studies with detailed information. Though in this study there was considerable clinical information available, 52 people (40%) either declined to take part in the study or were excluded as the questionnaires were not fully completed. This represents a significant loss of power for the study.
The reluctance of patients from the neurology outpatient clinics to see psychiatrists has been commented on already 12 and clinical screening for depressive illness by a psychiatrist would be impractical and unacceptable to most patients. A screening tool must, therefore, be used which cannot be 100% sensitive and does not have the flexibility that a clinical assessment does. For this study, the HAD was used as it was designed for use in the medically unwell population. It has been suggested that whilst the HAD is a relatively sensitive instrument (80-100%) it has a low positive predictive value 9 and so should be used (as in this case) as a screening instrument rather than one for diagnosis. This identifies two possible sources of error in this study: firstly four patients scoring above the cut-off point of 8 and declining clinical interview by the psychiatrist were excluded from the study, thus a significant group was lost, and secondly there would be up to 20% of people with depressive illness not identified by the rating scale and, thus included in the wrong group for comparison.
CONCLUSIONS
In this study, the only features of people with epilepsy found to be statistically significantly associated with the presence of a depressive illness were: a right sided focus/lesion, diagnosis in adulthood, a perception that having epilepsy severely affects mobility or general activity and having one or more attacks each month. Many of these findings are not in accordance with previous studies investigating the problem, though establishing robust anatomical associations between the two disorders has been difficult and this study, to some extent adds further to the uncertainty. It is interesting, however, that both anatomical and psychosocial variables have shown significant associations which would support a multifactorial model.
